Autor: |
Priestley P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Baber J; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Lolkema MP; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Steeghs N; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., de Bruijn E; Hartwig Medical Foundation, Amsterdam, The Netherlands., Shale C; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Duyvesteyn K; Hartwig Medical Foundation, Amsterdam, The Netherlands., Haidari S; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., van Hoeck A; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands., Onstenk W; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., Voda M; Hartwig Medical Foundation, Amsterdam, The Netherlands., Bloemendal HJ; Meander Medisch Centrum, Amersfoort, The Netherlands.; Radboud University Medical Center, Nijmegen, The Netherlands., Tjan-Heijnen VCG; Maastricht University Medical Center, Maastricht, The Netherlands., van Herpen CML; Radboud University Medical Center, Nijmegen, The Netherlands., Labots M; VU Medical Center, Amsterdam, The Netherlands., Witteveen PO; Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Smit EF; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., Sleijfer S; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Voest EE; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl. |